Roche's Arthritis Drug, Used As COVID-19 Treatment, Faces Supply Shortage

Roche Holdings AG's drug Actemra, or tocilizumab, was granted FDA emergency use authorization for critically ill COVID-19 patients after showing it cut the risk of death.

Less than two months after that development, the company is running out of supplies of the drug.